title: Household transmission of haemolytic uraemic syndrome associated with Escherichia coli O104:H4, south-western France, June 2011.
abstract: Following the outbreak of haemolytic uraemic syndrome (HUS) on June 2011 in south-western France, household transmission due to Escherichia coli O104:H4 was suspected for two cases who developed symptoms 9 and 10 days after onset of symptoms of the index case. The analysis of exposures and of the incubation period is in favour of a secondary transmission within the family. Recommendations should be reinforced to prevent person-to-person transmission within households.
authors.affiliation: French Institute for Public Health Surveillance (Institut de Veille Sanitaire; InVS), Regional office Cire Aquitaine , Bordeaux, France.
authors.forename: B
authors.initials: B
authors.lastname: Aldabe
authors.forename: Y
authors.initials: Y
authors.lastname: Delmas
authors.forename: G
authors.initials: G
authors.lastname: Gault
authors.forename: B
authors.initials: B
authors.lastname: Vendrely
authors.forename: B
authors.initials: B
authors.lastname: Llanas
authors.forename: M
authors.initials: M
authors.lastname: Charron
authors.forename: C
authors.initials: C
authors.lastname: Castor
authors.forename: N
authors.initials: N
authors.lastname: Ong
authors.forename: Fx
authors.initials: F
authors.lastname: Weill
authors.forename: P
authors.initials: P
authors.lastname: Mariani-Kurkdjian
authors.forename: F
authors.initials: F
authors.lastname: Terrier
authors.forename: M
authors.initials: M
authors.lastname: Desjardin
authors.forename: J
authors.initials: J
authors.lastname: Simoes
authors.forename: B
authors.initials: B
authors.lastname: Le Bihan
authors.forename: C
authors.initials: C
authors.lastname: Combe
authors.forename: P
authors.initials: P
authors.lastname: Rolland
mesh_terms: D015746:Abdominal Pain / Q000209:etiology; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D002675:Child, Preschool; D016358:Contact Tracing; D003967:Diarrhea / Q000150:complications / Q000453:epidemiology; D004196:Disease Outbreaks; D004926:Escherichia coli / Q000145:classification / Q000235:genetics / Q000302:isolation & purification*; D004927:Escherichia coli Infections / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000635:transmission*; D005191:Family Characteristics; D005243:Feces / Q000382:microbiology; D005602:France / Q000453:epidemiology; D006463:Hemolytic-Uremic Syndrome / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D006801:Humans; D008297:Male; D054323:Shiga-Toxigenic Escherichia coli / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification*; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D002511:Cephalosporins